Summary

Sleep apnea is a common and serious sleep disorder that affects millions of people in the Middle East and Africa. The prevalence of sleep apnea is likely to increase in the region due to the aging population and the increasing prevalence of obesity. There are a number of things that can be done to improve the diagnosis and treatment of sleep apnea in the Middle East and Africa, including raising awareness of the condition, improving access to sleep studies, and expanding access to treatment. Obesity is a significant risk factor for sleep apnea. With a rising prevalence of obesity in some countries in the Middle East and Africa, there may be a corresponding increase in the number of individuals with sleep apnea, boosting the demand for therapeutic devices. The aging population in some Middle Eastern and African countries contributes to an increased prevalence of sleep apnea. Older individuals are more prone to sleep disorders, and the demand for therapeutic devices is likely to grow as the population ages. As cultural attitudes towards sleep and its importance to overall health evolve, there may be an increased recognition of sleep disorders, including sleep apnea. This cultural shift can lead to more individuals seeking diagnosis and treatment. The adoption of innovative payment models, such as pay-per-use or subscription-based models for sleep apnea devices can provide individuals with more flexible and affordable options for obtaining therapeutic devices. The rise of medical tourism in certain Middle Eastern and African countries may contribute to increased demand for sleep apnea diagnosis and treatment. Healthcare facilities catering to medical tourists may invest in advanced sleep disorder management services. Integrating sleep apnea management into chronic disease management programs can enhance overall patient care. Considering the connections between sleep apnea and conditions like diabetes and cardiovascular disease, this integrated approach may drive the use of therapeutic devices.

According to the research report "Middle East & Africa Sleep Apnea Therapeutic Devices Market Outlook, 2028," published by Bonafide Research, the Middle East and Africa Sleep Apnea Therapeutic Devices market was valued more than USD 270 Million in 2022. The adoption of telemedicine and remote patient monitoring solutions has been on the rise globally. In the context of sleep apnea, this trend might involve the use of digital health platforms to remotely monitor patients' sleep patterns and therapy adherence. For devices like CPAP machines that use masks, on-going innovations in mask designs may focus on improving comfort, reducing skin irritation, and enhancing the overall user experience. This could include the use of new materials and ergonomic designs. Sleep apnea devices may integrate additional features such as sleep tracking and monitoring. This could provide users with comprehensive insights into their sleep patterns, aiding both patients and healthcare providers in assessing the effectiveness of therapy. Increased digitalization in healthcare may lead to the development of e-health platforms dedicated to sleep apnea management. These platforms could provide educational resources, remote consultations, and a centralized hub for patient data. Efforts to raise awareness about sleep apnea may expand beyond urban centers to reach individuals in non-urban or rural areas. This could involve community outreach programs, telemedicine initiatives, and educational campaigns tailored to specific cultural contexts. The integration of sleep apnea monitoring features into wearable devices, such as smartwatches or fitness trackers, could become more common. This approach could enhance convenience and user engagement in monitoring sleep health. The development and adoption of mobile health applications focused on sleep apnea management may increase. These apps could include features for tracking sleep patterns, monitoring therapy adherence, and providing educational resources.

The Middle East & Africa Sleep Apnea Therapeutic Devices Market based on country the market is categorized into United Arab Emirates, Saudi Arabia and South Africa. In the United Arab Emirates, a rapidly evolving healthcare landscape, coupled with a growing awareness of sleep disorders, contributes to the expanding market for sleep apnea devices. The UAE's commitment to investing in advanced medical technologies aligns with the increasing prevalence of sleep apnea and the demand for innovative therapeutic solutions. Saudi Arabia, as a prominent player in the region's healthcare sector, demonstrates a robust market for sleep apnea therapeutic devices. The country's proactive approach to healthcare infrastructure development, coupled with rising awareness among healthcare professionals and the general population, fosters a conducive environment for market growth. The Saudi Arabian market reflects a growing emphasis on patient-centric care and the integration of cutting-edge technologies to address sleep apnea. A decrease in physical activity and an increase in the intake of highly processed foods and beverages are two examples of the lifestyle changes brought about by rapid economic development and urbanisation. Thus, the current obesity rate in Saudi Arabia is over 20% and the overweight rate is over 50%. Furthermore, according to WHO data from 2020, Saudi Arabia accounted for 834 fatalities from hypertension, or 0.62% of all deaths. Its age-adjusted death rate of 4.28 per 100,000 inhabitants puts Saudi Arabia at 160th place in the world.

The market is segmented into various product categories, such as Positive Airway Pressure (PAP) Device, Adaptive Servo-Ventilation (ASV), Airway Clearance Systems, Oxygen Devices, Oral Appliances and Others. ASV Systems are particularly effective in treating complex sleep apnea cases, which involve a combination of obstructive and central sleep apnea events. These devices can adapt to the patient's breathing patterns and provide the necessary respiratory support, making them suitable for a broader range of sleep apnea conditions. ASV Systems are designed to adapt the air pressure levels in real-time based on the patient's breathing patterns. This adaptive pressure adjustment optimizes the therapy, providing the necessary support during periods of reduced or absent breathing. ASV devices are versatile in addressing different types of respiratory events, including apneas and hypopneas. Their adaptability makes them suitable for individuals with varying degrees of severity and different types of sleep apnea, offering a comprehensive therapeutic solution. ASV Systems often come with features that enhance patient comfort, such as ramp-up settings, humidification options, and quieter operation. Improved comfort contributes to better patient adherence to therapy, ensuring the effectiveness of treatment in the long term. As awareness of sleep apnea increases, more individuals are seeking diagnosis and treatment. Healthcare professionals are becoming more familiar with the various therapeutic options, including ASV Systems, leading to their increased prescription for appropriate cases.

The market's end-user segment is split up into Home care Settings & Individuals and Sleep laboratories & Hospitals. Home care settings provide individuals with the flexibility to customize their sleep apnea therapy. This includes the choice of masks, adjustments to therapy settings, and the ability to create a sleep environment that promotes comfort and adherence. Home-based care can result in cost savings for both healthcare providers and patients. It reduces the need for hospital visits and overnight stays, making sleep apnea therapy more cost-effective and accessible to a broader population. Evolving healthcare policies and a growing recognition of the effectiveness of home-based care contribute to the prominence of the Home Care Settings & Individuals segment. Policies that support and promote home-based sleep apnea therapy drive market growth. The rising awareness of sleep apnea and its potential health consequences has led to an increased demand for convenient and accessible treatment options. Individuals are more likely to seek and adhere to therapy when it can be managed in the familiar environment of their homes. Home care settings often provide access to patient education resources, including instructional materials and online support. These resources empower individuals to better understand their condition, treatment options, and the importance of therapy adherence. Home-based care allows for the development of customized treatment plans tailored to the individual needs and preferences of patients. This personalization enhances the overall patient experience and contributes to long-term therapy compliance.

Companies Covered in this report:

ResMed Inc. , Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Itamar Medical Ltd, Nihon Kohden Corporation, LivaNova, PLC , Cardinal Health, Inc, Drägerwerk AG & Co. KGaA.

Considered in this report

• Geography: Middle East & Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Europe Sleep Apnea Therapeutic Devices market Outlook with its value and forecast along with its segments
• Country-wise Sleep Apnea Therapeutic Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United Arab Emirates
• Saudi Arabia
• South Africa

By Product

• Positive Airway Pressure (PAP) Device
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Devices
• Oral Appliances
• Others (Nasal dilators, Positional therapy, Surgical procedures, Electrical stimulation devices)

By End User

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.







***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents